New intravenous drug therapies possible due to Microfluidizer processing
by Microfluidics Corp.
In this case study, Microfluidics Corp.'s Microfluidizer processor supports a Purdue University study involving intravenous delivery of drugs by supplying large quantities of very small lipid droplets whose uniform size can be reproduced from trial to trial. The small size of the lipid droplets produced by the Microfluidizer processor makes it possible to inject them into the blood without risking blockage of small blood vessels.
| Published: | 1998 |
| Format: | |
| Length: | 2 pages |
| Type: | Case Study |
| Language: | English |
.
SPONSORED REPORTS
